Advertisement

Neurocritical Care

, Volume 2, Issue 2, pp 183–184 | Cite as

Oral clopidogrel load in aspirin-resistant capsular warning syndrome

  • Christopher D. Fahey
  • Mark J. Alberts
  • Richard A. Bernstein
Practical Pearls

Abstract

Introduction: Capsular warning syndrome (CWS) carries a significant risk of permanent stroke. There are no proven therapies for preventing completed stroke in this unstable situation.

Methods: Clinical observation in two patients with aspirin-resistant CWS treated with a loading dose of oral clopidogrel.

Results: Both patients had excellent neurological outcome, although one sustained an asymptomatic brain infarction.

Conclusion: High-dose oral clopidogrel plus aspirin merits formal evaluation in high-risk transient brain ischemia such as CWS, preferably in a randomized trial compared to aspirin alone.

Key Words

Ischemic stroke antiplatelet therapy transient ischemic attack acute brain ischemia Capsular warning syndrome 

References

  1. 1.
    Donnan GA, O’Malley HM, Quang L, Hurley S, Bladin PF. The capsular warning syndrome. Pathogenesis and clinical features. Neurology 1993;43:957–962.PubMedGoogle Scholar
  2. 2.
    Staaf G, Geijer B, Lindgren A, Norrving B. Diffusion-weighted MRI findings in patients with capsular warning syndrome. Cerebrovasc Dis 2004;17:1–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Benito-León J, Alvarez-Linerá J, Porta-Etessam J. Detection of acute pontine infarction by diffusion-weighted MRI in capsular warning syndrome. Cerebrovasc Dis 2001;11:350,351.PubMedCrossRefGoogle Scholar
  4. 4.
    Farrar J, Donnan GA. Capsular warning syndrome preceding pontine infarction. Stroke 1993;24:762.PubMedGoogle Scholar
  5. 5.
    Donnan GA, O’Malley HM, Quang L, Hurley S. The Capsular warning syndrome: The high risk of early stroke. Cerebrovasc Dis 1996;6:202–207.Google Scholar
  6. 6.
    Dobkin BH. Heparin for lacunar stroke in progression. Stroke 1983;14:421–423.PubMedGoogle Scholar
  7. 7.
    Lalive PH, Mayor I, Sztajzel R. The role of blood pressure in lacunar strokes preceded by TIAs. Cerebrovasc Dis 2003;16:88–90.PubMedCrossRefGoogle Scholar
  8. 8.
    CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–1339.CrossRefGoogle Scholar
  9. 9.
    Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502.PubMedCrossRefGoogle Scholar
  10. 10.
    Savcic M, Hauert J, Bachmann F. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 1999;25:15–19.PubMedGoogle Scholar
  11. 11.
    Thebault JJ, Kieffer G, Cariou R. Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost 1999;25:3–8.PubMedGoogle Scholar
  12. 12.
    Frey J. Capsular warning syndrome. Neurology 1994;44(1):195,196.PubMedGoogle Scholar
  13. 13.
    Batista P, Soares F, Oliveira V, Ferro JM. No evidence for microembolism in clustering transient ischemic attacks. Cerebrovasc Dis 2002;14(3–4)260.PubMedCrossRefGoogle Scholar
  14. 14.
    Terai S, Hori T, Miake S, Tamaki K, Saishoji A. Mechanism in progressive lacunar infarction: a case report with magnetic resonance imaging. Arch Neurol 2000;57:255–258.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2005

Authors and Affiliations

  • Christopher D. Fahey
    • 1
  • Mark J. Alberts
    • 1
  • Richard A. Bernstein
    • 1
  1. 1.Stroke Program, Ken and Ruth Davee Department of Neurology and Clinical Neurological SciencesFeinberg School of Medicine of Northwestern UniversityChicago

Personalised recommendations